Can Perioperative Antibiotic Choice Impact Rates of Infectious Complications After Percutaneous Nephrolithotomy? A Single-Blind, Prospective Randomized Trial
Recommended Citation
Wright HC, Kachroo N, Jain R, Kamal M, Fedrigon Iii D, Corrigan D, Zampini A, De S, Noble M, Isac W, Monga M, and Sivalingam S. Can perioperative antibiotic choice impact rates of infectious complications after PCNL? A single-blind prospective randomized trial. J Endourol 2023.
Document Type
Article
Publication Date
1-1-2024
Publication Title
Journal of endourology / Endourological Society
Abstract
OBJECTIVE: National guidelines recommend peri-procedural antibiotics prior to percutaneous nephrolithotomy (PCNL), yet it is not clear which is superior. We conducted a randomized trial to compare two guideline recommended antibiotics: ciprofloxacin (cipro) versus cefazolin, on PCNL outcomes, focusing on the development of systemic inflammatory response syndrome (SIRS) criteria.
METHODS: Adult patients who were not considered high risk for surgical or infectious complications undergoing PCNL were randomized to receive either cipro or cefazolin perioperatively. All had negative pre-operative urine cultures. Demographic and peri-operative data were collected, including SIRS criteria, intra-operative urine culture, duration of hospitalization, and need for intensive care. SIRS is defined by ≥2 of the following: body temperature < 96.8 °F or >100.4 °F, heart rate > 90 bpm, respiratory rate >20 per minute, WBC count <4000 or > 12,000 cells/mm³.
RESULTS: One hundred and forty seven patients were enrolled and randomized (79 cefazolin, 68 cipro). All pre-operative characteristics were similar (p>0.05), except for mean age, which was higher in the cipro group (64 vs. 57, p=0.03). Intra and post-operative findings were similar, with no difference between groups (p>0.05), except a longer mean hospital stay in the cefazolin group (2 hours longer, p=0.02). There was no difference between SIRS episodes on both univariate and multivariate analysis.
CONCLUSIONS: Despite the relatively broader coverage for urinary tract pathogens with ciprofloxacin, this prospective randomized trial did not show superiority over cefazolin. Our findings therefore support two appropriate options for perioperative antibiotic prophylaxis in patients undergoing PCNL who are non-high risk for infectious complications.
Medical Subject Headings
Adult; Humans; Middle Aged; Anti-Bacterial Agents; Cefazolin; Ciprofloxacin; Kidney Calculi; Nephrolithotomy, Percutaneous; Postoperative Complications; Prospective Studies; Single-Blind Method; Systemic Inflammatory Response Syndrome
PubMed ID
37917100
ePublication
ePub ahead of print
Volume
38
Issue
1
First Page
2
Last Page
7